Literature DB >> 11416632

Combination Drug Therapy in the Management of Hypertension: When, With What, and How?

Marvin Moser1, Thomas Pickering, James R. Sowers.   

Abstract

Entities:  

Year:  2000        PMID： 11416632

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  8 in total

1.  Control and management of hypertension at a university health centre in oman.

Authors:  Abdulaziz Almahrezi; Ibrahim Al-Zakwani; Ayman Al-Aamri; Samia Al-Khaldi; Nisrin Al-Zadjali; Mohammed Al-Hatali; Abdullah Al-Shukeili
Journal:  Sultan Qaboos Univ Med J       Date:  2008-07

2.  The more things change, the more they remain the same.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-04       Impact factor: 3.738

Review 3.  Update on the management of hypertension: do recent clinical trial results indicate a change in national recommendations for therapy?

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

4.  Ten years and counting: the journal of clinical hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 3.738

Review 5.  Strategies for initial management of hypertension.

Authors:  Rajeev Gupta; Soneil Guptha
Journal:  Indian J Med Res       Date:  2010-11       Impact factor: 2.375

Review 6.  Drug Interactions in Parkinson's Disease: Safety of Pharmacotherapy for Arterial Hypertension.

Authors:  Anna Bitner; Paweł Zalewski; Jacek J Klawe; Julia L Newton
Journal:  Drugs Real World Outcomes       Date:  2015-03

Review 7.  Update on the management of hypertension: recent clinical trials and the JNC 7.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-10       Impact factor: 3.738

Review 8.  Rationale for combination therapy in the management of hypertension.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Nov-Dec       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.